EDGAR Filing Documents for 0001193125-15-275756

Form 8-K - Current report:

SEC Accession No. 0001193125-15-275756

Filing Date

2015-08-04

Accepted

2015-08-04 08:01:00

Documents

Period of Report

2015-08-03

Items

Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d54116d8k.htm	8-K	17160
2	EX-99.1	d54116dex991.htm	EX-99.1	160285
3	EX-99.2	d54116dex992.htm	EX-99.2	5189
4	GRAPHIC	g54116ex99_1pg001.jpg	GRAPHIC	9905
5	GRAPHIC	g54116ex99_2logo.jpg	GRAPHIC	8548
	Complete submission text file	0001193125-15-275756.txt		209834

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195

Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604

Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 151024055
SIC: 2834 Pharmaceutical Preparations